Oral Phosphodiesterase Type 5 Inhibitors Alleviate Recurrent Priapism Complicating Thalassemia Intermedia: A Case Report
- 1 July 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 6 (7) , 2068-2071
Abstract
Introduction: Recurrent ischemic priapism still remains a serious and difficult to treat complication of certain hematological disorders. Elucidation of the underlying pathophysiologic mechanisms and application of new effective prophylactic treatments are needed. Aim: To present the efficacy of phosphodiesterase type 5 inhibitors (PDE5is) as a preventive measure against ischemic priapism recurrences complicating thalassemia intermedia. Methods: We report on the case of a 19-year-old Caucasian man with thalassemia intermedia complicated by recurrent episodes of priapism following therapeutic splenectomy. After failure of conventional measures to control recurrences, a trial of long-term PDE5is use was initiated. Main Outcome Measures: PDE5is efficacy based on clinical patient history. Results: Within 2 months of PDE5i preventive strategy, priapism recurrences nearly resolved. At 6 months, prophylaxis was discontinued. At 12 months, the patient reported clear improvement and satisfaction, experiencing rare episodes of priapism and a physiologic erectile function. Conclusions: PDE5 dysregulation seems to be an underline pathogenetic mechanism of thalassemia intermedia-associated priapism. It appears that PDE5is might have a role in the clinical management of such patients and their preventive efficacy warrants further testing in clinical trials.Keywords
This publication has 11 references indexed in Scilit:
- Oral Phosphodiesterase Type 5 Inhibitors: Nonerectogenic Beneficial UsesThe Journal of Sexual Medicine, 2008
- Glucose-6-Phosphate Dehydrogenase Deficiency: An Etiology for Idiopathic Priapism?The Journal of Sexual Medicine, 2008
- Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent PriapismThe Journal of Sexual Medicine, 2006
- Thalassemia intermedia: RevisitedBlood Cells, Molecules, and Diseases, 2006
- Hemolysis-associated priapism in sickle cell diseaseBlood, 2005
- Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis.Journal of Urology, 2003
- Sildenafil relieves priapism in patients with sickle cell diseaseThe American Journal of Medicine, 2002
- High Flow Priapism Associated with Sickle Cell DiseaseJournal of Urology, 1995
- Priapism and thalassaemia intermediaBritish Journal of Surgery, 1986
- Recurrent priapism following splenectomy for thalassaemia intermediaBritish Journal of Surgery, 1986